Eric Arzubi: The Hidden Crisis in Healthcare Ownership and Leadership
Eric Arzubi, Co-Founder Frontier Psychiatry and Assistant Clinical Professor, Yale Child Study Center, shared a post on LinkedIn:
”Lawyers can own law firms. Doctors cannot own hospitals.
You read that right.
ABA Rule 5.4 has protected lawyer ownership of law firms since 1983. Non-lawyers cannot own, manage, or share profits from a law practice.
Medicine has no such protection.
Only 5 percent of U.S. hospital CEOs are physicians. In 2010, the ACA banned doctors from building new hospitals at all. Section 6001 was a backroom deal. The American Hospital Association lobbied for the ban as the price of backing the ACA.
Physicians were traded away. Private equity walked in.
Here is what happened:
- 25 percent rise in hospital acquired conditions after private equity buyouts
- 18 percent cut to emergency room staffing budgets at private equity owned hospitals
- Hospital assets dropped 24 percent within two years of private equity purchase
- Average private equity hospital star rating is 2.5 out of 5
Here is what physician leadership looks like:
- Quality scores 25 percent higher at physician led hospitals
- Charges one third lower at physician owned hospitals
- Mayo Clinic, Cleveland Clinic, Johns Hopkins are physician led for a century
Think about who suffers when the people who understand medicine do not control it:
- The nurse whose staffing ratio was cut to protect a quarterly earnings report
- The doctor who went into medicine to lead but now takes orders from an MBA who has never touched a patient
- The rural town whose hospital closed because it was not profitable enough for investors
The AMA and more than 90 medical groups now back repealing the ban. Bills to lift it sit in Congress with bipartisan support.
But 15 years of inaction raises a hard question: is lobbying without power enough
We do not have a healthcare leadership crisis. We have a healthcare ownership crisis.”

Stay updated with Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden